key: cord-0287841-4j7cxygq
authors: Kriplani, Nisha; Clohisey, Sara; Fonseca, Sonia; Fletcher, Sarah; Lee, Hui-Min; Ashworth, Jordan; Kurian, Dominic; Lycett, Samantha J.; Tait-Burkard, Christine; Kenneth Baillie, J.; Woolhouse, Mark E. J.; Carding, Simon R.; Stewart, James P.; Digard, Paul
title: Secreted SARS-CoV-2 ORF8 modulates the cytokine expression profile of human macrophages
date: 2021-08-18
journal: bioRxiv
DOI: 10.1101/2021.08.13.456266
sha: c946ed83d99252386b2a2dac4752ee44830ca0ac
doc_id: 287841
cord_uid: 4j7cxygq

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still adapting to its new human host. Attention has focussed on the viral spike protein, but substantial variation has been seen in the ORF8 gene. Here, we show that SARS-CoV-2 ORF8 protein undergoes signal peptide-mediated processing through the endoplasmic reticulum and is secreted as a glycosylated, disulphide-linked dimer. The secreted protein from the prototype SARS-CoV-2 virus had no major effect on viability of a variety of cell types, or on IFN or NF-κB signalling. However, it modulated cytokine expression from primary CSF1-derived human macrophages, most notably by decreasing IL-6 and IL-8 secretion. Furthermore, a sequence polymorphism L84S that appeared early in the pandemic associated with the Clade S lineage of virus, showed a markedly different effect, of increasing IL-6 production. We conclude that ORF8 sequence polymorphisms can potentially affect SARS-CoV-2 virulence and should therefore be monitored in sequencing-based surveillance.

Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, is a positive sense RNA virus belonging to the Coronaviridae family [1] .

Its RNA genome of around 30 kb contains 12 major open reading frames (ORFs), which with polyprotein processing and various alternative translation events encode upwards of 30 proteins [2] . Based on their function, these can be variously classified as replication proteins (e.g. the many products of the Orf1a/b polyprotein), structural proteins (including S, M, E and N) and accessory proteins that include the products of ORF3a, ORF6, ORF7a/b, ORF8, ORF9b/c and ORF10 [3] . Coronavirus accessory proteins are not necessarily essential for replication of the virus in vitro and tend to be less well conserved between different viral species [3] [4] [5] [6] [7] [8] ,

Nonetheless, accessory proteins are often involved in immune modulation and can play essential roles in virulence, pathogenesis, and host-adaptation. In line with this, SARS-CoV-1 acquired a 29 bp deletion disrupting ORF8 early in the epidemic, which was associated with host adaptation [9] [10] [11] [12] . Similarly, in the early stages of the COVID-19 pandemic, the SARS-CoV-2 ORF8 gene was an early hotspot of mutational change, with several studies identifying a coding change (L84S) as being under significant selection pressure [13] [14] [15] [16] . Large gene deletions affecting SARS-CoV-2 ORF8 have also been seen, and as with SARS-CoV-1, these, as well as the L84S polymorphism, have been linked to changes in disease severity [8, [17] [18] [19] .

Understanding the function of SARS-CoV-2 ORF8 polypeptide is therefore likely to provide insights into viral adaptation and pathogenesis. An intact ORF8 gene is non-essential for SARS-CoV-1 replication in tissue culture, while the intact ORF8 polypeptide was shown to be glycosylated and partially resident in the endoplasmic reticulum (ER), as well as being associated with inhibition of innate immune signalling [20] [21] [22] . Bioinformatics analyses of SARS-CoV-2 ORF8 similarly indicated the presence of a cleavable signal peptide (SP) [23, 24] and consistent with this, a subsequent study detected SP-dependent secretion of ORF8 in transfected cell culture supernatants as well as in the serum of patients infected with SARS-CoV-2 [25] . SARS-CoV-2 ORF8 has also been proposed to inhibit various steps of the interferon signalling pathway [26] [27] [28] [29] , although not all studies have confirmed this [30] . Two studies have also linked ORF8 expression to induction of ER stress and the unfolded protein response [26, 31] . ORF8 has also been suggested to facilitate immune evasion by directly interacting with and downregulating MHC-I molecules in various cell types [32] . Conversely, it has been suggested to contribute to "cytokine storms" through an interaction with the IL-17 receptor [33] . Here, we confirm SP-dependent secretion of SARS-CoV-2 ORF8 and show that the secreted form is predominantly a disulphide-linked dimer glycosylated at position 78.

Furthermore, we show that secreted ORF8 is capable of modulating the cytokine response of human blood monocytes-derived macrophages (MDMs) in a manner specifically affected by the L84S polymorphism.

Cell culture and transfections: A549 (Human adenocarcinoma alveolar basal epithelial cell line), X293T (Human Embryonic Kidney cell line) and HEK-Blue IFN α/β cells (InvivoGen) were cultured in Dulbecco's modified eagle's medium (DMEM, Sigma Aldrich) with 10% (v/v) Foetal Bovine Serum (FBS) (Life Technologies), 2 mM L-Glutamine (Life Technologies), 100 U/mL penicillin (Gibco) and 100 µg/mL streptomycin (Gibco). For HEK-Blue IFNα/β cells, 30 µg/mL blasticidin (InvivoGen) and 100 µg/mL zeocin (InivoGen) were also added to complete medium. Similarly, the human monocyte cell line THP1-Blue expressing an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene (InvivoGen) were cultured in RPMI-1640 (Sigma Aldrich) with 10% (v/v) FBS (Biosera), 2 mM L-Glutamine, 100 U/mL penicillin, 100 µg/ml streptomycin, 30 µg/mL blasticidin and 100 µg/mL normocin. To maintain selection pressure, 10 µg/ml blasticidin was added every other passage. Primary human CD14 + monocytes were isolated from fresh blood from volunteer donors under ethical approval from the Lothian Research Ethics Committee (11/AL/0168) as described before [34] .

Primary monocytes were seeded in 96-well or 48-well cell culture plates in RPMI supplemented with 10% (v/v) FBS, 2 mM L-Glutamine, 100 U/mL penicillin, 100 µg/ml streptomycin and 100 ng/ml rhCSF-1 for 7 days to facilitate differentiation into macrophages. Mass spectrometry: LC-MS analysis was performed using a RSLCnano system (Thermo Fisher Scientific) coupled to a micrOTOF QII mass spectrometer (Bruker) on in-gel trypsin digested protein bands excised from Coomassie Blue-stained SDS-PAGE gels [38] .

Immunofluorescence: A549 cells seeded on glass coverslips were washed with PBS and then fixed with 4% formaldehyde in PBS (Sigma) for 20 min prior to permeabilisation with 1% Triton Cytokine profiler assay: A subset of clarified (by centrifugation at 400 x g for 10 minutes) supernatants from MDMs of three donors were pooled together. Cytokine profiling of these pooled supernatants was performed using a human cytokine array kit (human cytokine array kit, panel A; R&D Systems) and near-infrared fluorescence detection using IRDye 800CW

Streptavidin (Li-Cor Biosciences).

Inspection of the ORF8 protein sequence indicates a small protein of 121 aa (molecular weight ~11kDa) with a predicted cleavable signal peptide at the N-terminus, no further transmembrane domain and an N-glycosylation motif at amino acid 78, as well as an abundance of cysteine residues ( Figure 1A ). Taken together, these suggested the hypothesis that ORF8 is a secreted viral chemokine, or "virokine". Analysis of naturally occurring ORF8 polymorphisms early in the COVID-19 pandemic using sequences available on GISAID [39] shows that the first recorded L84S mutation was detected in one of the 24 sequences now available from Wuhan, China in December 2019 (Strain Wuhan_IME-WH01, Genbank accession MT291826). In January, February and March 2020, the L84S mutation was present in 35%, 18% and 11% of the available GISAID sequences (Table S1, Figure S1 ), corresponding (70%) and A.3 (28%) for the period December 2019-March 2020 ( Figure S1 ), and these sequences with both L84S and V62L were mostly (86%) detected in North America ( Figure S2 ).

The early appearance and spread of L84S possibly along with V62L is suggestive of host adaption. As a first test of these hypotheses, we constructed a series of C-terminally FLAGtagged ORF8 constructs and expressed them in X293T cells, along with (as a positive control for a small cellular secreted protein [40] ) a similarly FLAG-tagged version of the human showed the presence of two peptides from ORF8 (underlined, Figure 1A ). Secretion of ORF8 was blocked by the CS and SP mutations and reduced by alteration of the glycosylation motif ( Figure 1B, right hand panel) . Treatment with tunicamycin, an inhibitor of glycosylation and inducer of ER stress [41, 42] blocked secretion of the WT-f ORF8 polypeptide and shifted the balance of the two larger intracellular isoforms towards the middle species ( Figure 1C ).

Overall, this suggests that the primary ORF8 polypeptide is processed by removal of the SP and an initial round of glycosylation in the ER, followed by further glycosylation and secretion of this mature form ( Figure 1D ). A final intracellular species apparently results from further N-terminal cleavage in the secretory pathway.

The crystal structure of ORF8 produced from Escherichia coli and refolded in vitro indicates a disulphide-linked dimer [43] . To test if this occurred for the fully glycosylated form synthesised in mammalian cells, we analysed the mature secreted form by SDS-PAGE with and without reducing agent in the sample buffer. In the absence of b-mercaptoethanol, a prominent band migrating at the size expected for a dimer was seen, as well a small amount of the monomer form ( Figure 1E ), indicating that ORF8 is primarily secreted from mammalian cells as a disulphide-linked dimer.

To test if the addition of the FLAG tag affected biosynthesis of ORF8, we examined cell lysates and supernatants from cells transfected with either empty vector, the WT-f construct or one containing an untagged ORF8 gene by western blotting with an anti-ORF8 polyclonal antibody [37] . Similarly sized polypeptides were detected from both tagged and untagged constructs in the cell lysate and supernatants ( Figure 1F ), suggesting that the FLAG tag had no major effect on ORF8 secretion. Finally, we examined lysates from cells transfected with the ORF8 constructs or infected with SARS-CoV-2, which revealed that authentic virus infection produced a similarly-sized polypeptide to the exogenously-expressed protein ( Figure 1G Figure S3 ). In contrast, the SP mutant gave a more punctate cytoplasmic distribution which did not colocalise with the ER.

ORF8 homologues from SARS-CoV-1 i.e., ORF8ab, ORF8a and ORF8b, have been reported to variously induce apoptosis, modulate cellular DNA synthesis, induce protein degradation (by ubiquitination) and interfere with the host immune response [5, 8, 44] . Less functional information is available on SARS-CoV-2 ORF8 but here too it has been implicated in immune evasion [27, 45] . Our virokine hypothesis predicted that secreted ORF8 would act as a paracrine modulator of cell function; either by inducing a response and/or by reducing the response of cells to another stimulus. To test this, supernatants from transfected X293T cells were harvested and assayed for effects when added to the medium over fresh cells. Unlike SARS-CoV-1 ORF8 polypeptides [44, 46] , ORF8 of SARS-CoV-2 either in expressed or secreted form did not notably affect cell viability of X293T or A549 cells ( Figure S4 ), although A549 cells appeared sensitive to apoptosis induced by expression of the SP mutant ( Figure S3 ). Next, we tested the role of secreted ORF8 in interferon (IFN) signalling. When added to A549 cells, the ORF8 polypeptides did not induce detectable type I IFN secretion as assessed by bio-assay using HEK-Blue cells, and nor did they inhibit type I IFN secretion when the cells were stimulated by poly I:C transfection ( Figure 3A) . Moreover, when an IFNb dose response curve was performed in the presence of secreted ORF8 (either WT or the L84S variant), no significant effects were observed ( Figure 3B ). The effects of secreted ORF8 on NF-κB signalling were also assessed, using THP1-Blue-NF-κB cells; a reporter cell line that contains a SEAP reporter gene under an NF-κB-inducible promoter [47] . Supernatants from ORF8 expressing cells or control cells were added to the reporter cells with or without the NF-κB signalling activator LPS. However, the ORF8-containing supernatants did not induce NF-κB signalling on their own and nor did they exhibit any antagonistic effect against LPS-induced responses ( Figure 3C ). Thus, secreted ORF8 had no obvious effect on IFN signalling in epithelial cell models or NF-κB signalling in a monocyte model.

Macrophages are an indispensable component of the innate immune system and upon viral infections, alter their cytokine profile to mount a greater anti-viral response [48] . A dysregulated monocytic response is thought to be key to severe pathology in SARS-CoV-2

infections [49] . Accordingly, we next investigated the effect of ORF8 on the cytokine/chemokine secretion profile of primary human macrophages. Monocyte-derived macrophages (MDMs) were incubated with supernatants containing the panel of ORF8 polypeptides in the presence or absence of poly I:C or IFNβ. Individual samples showed variability, perhaps reflecting differences in primary cells from donors, but overall, none of the secreted ORF8 or control cell supernatants had any significant effect on MDM viability, whilst transfection with poly I:C or treatment with IFNb reduced viability by around 50% ( Figure 4A ). As with A549 cells, the addition of ORF8-containing supernatants to MDMs did not induce type I IFN production by human macrophages and nor did it significantly alter type I IFN production after they were stimulated with poly I:C ( Figure 4B ).

The severity of COVID-19 disease has been linked to magnitude of the IL-6 response [50, 51] , in the absence of IFN was moderately suppressive to cytokine secretion, with most being reduced and none enhanced more than 2-fold ( Figure 5A ). Five cytokines showed greater than 2-fold reductions: IL-8, CXCL1 and TNFa by the WT-f supernatant, and CXCL10 and MIF by L84S ORF8. IFN treatment of the MDMs in the absence of ORF8 had a greater effect on cytokine production, with MIP-1, CXCL11, CCL5 and CXCL10 being upregulated more than 5fold and several down regulated more than 2-fold ( Figure 5A ). Both ORF8 polypeptides generally flattened the response to IFN treatment, with greater suppression of IL-2 by both ORF8 variants, IL-8 by WT but not L84S ORF8, conversely IL-27 production by L84S but not WT ORF8 and, as previously noted, differential effects on IL-6 release ( Figure 5B ). Thus, secreted ORF8 modulates cytokine production by primary human macrophages in a manner that varies according to naturally-occurring sequence polymorphisms.

Here, we confirm that SARS-CoV-2 ORF8 is secreted via a cleavable SP-dependent mechanism,

further showing that this is largely in the form of a disulphide-linked dimer glycosylated at position 78. We also provide evidence that secreted ORF8 acts as an immunomodulator, altering the cytokine profile of human primary MDMs in a way that depends on the ORF8 L84S sequence polymorphism.

Consistent with a previous study of SARS-CoV-2 ORF8 [25] , we found SP-dependent secretion of WT and L84S ORF8 and could trace a biosynthetic pathway up to a mature glycosylated and secreted disulphide-linked dimer. We also detected an additional smaller species (migrating at ~ 11 kDa) of unknown origin, that retained the C-terminal FLAG tag, thus most likely following an N-terminal cleavage event. This product was less abundant following mutation of either the SP, the SP cleavage site or the N-linked glycosylation signal, suggesting it is produced in the ER. Like others [26, 31] , we find that ORF8 over-expression induces ER stress (data not shown); whether formation of this isoform of ORF8 is involved in that process (or possibly other functions) remains to be determined.

Some, but not all studies have linked SARS-CoV-2 ORF8 to interference with innate immune signalling [26, 27, 29, 32] . Here, we found no major effect (positive or negative) of secreted ORF8 on IFN secretion, response, or NF-κB signalling in A549, X293T and THP-1 cells respectively. In this respect, our data are in broad agreement with a study that compared the response of human primary nasal epithelial cells to infection with WT or a naturally occurring ORF8 deletion (∆382 variant) and found no substantial difference in the IFN response [52] .

The reason(s) behind these discrepant results remain to be determined; cell type and assay method seem likely contributors. Cell type did play a role in the major effect we found for secreted ORF8 -modulating IL-6 production by human primary MDMs, as we did not recapitulate this effect in A549 cells, despite their being competent for IL-6 secretion (data not shown). Nevertheless, our finding that secreted ORF8 can alter cytokine secretion by MDMs supported our original hypothesis (also proposed by others [14] ) that it has an immunomodulatory "virokine" function. Furthermore, our data indicating that the two common ORF8 polymorphisms present early in the pandemic had differential effects is consistent with work associating the L84S variant with reduced clinical severity of disease [19] ; although perhaps counterintuitive because L84S increased IL-6 production in our system and higher IL-6 levels are accepted as prognostic of poorer clinical outcomes [50, 51] .

The mechanism by which ORF8 modulates cytokine expression remains to be determined. We have not tested purified ORF8 polypeptides so cannot exclude the possibility that ORF8 synthesis in cells induced the release of factors that alter MDM function (though this would be analogous to natural infection where infected epithelial cells will be the source of secreted ORF8), but the simplest hypothesis is that ORF8 acts directly on one or more MDM receptors.

Based on structural predictions and supported by interactome analyses, ORF8 has been suggested to interact with integrins [14, 28] . It has also been shown to interact with the IL-17

receptor [33] . Neither observation provides an immediate explanation of how IL-6 and other cytokine release by MDMs is perturbed, so further analysis is required. It is also not clear how the L84S polymorphism affects ORF8 function. We saw no obvious differences in intracellular processing or secretion and consistent with this, biochemical analyses indicate no substantial effect on protein stability other than decreased sensitivity to acidic (~ pH 6) conditions [53] . We also thank the anonymous donors who provided blood for experiments, as well as authors from the Originating laboratories responsible for obtaining the specimens and the Submitting laboratories where genetic sequence data were generated and shared via the GISAID Initiative, on which this research is based (supplementary tables S2 and S3). 

A pneumonia outbreak associated with a new coronavirus of probable bat origin

The coding capacity of SARS-CoV-2

Coronavirus biology and replication: implications for SARS-CoV-2

Accessory proteins of SARS-CoV and other coronaviruses

The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis

Characterization of accessory genes in coronavirus genomes

SARS coronavirus accessory proteins

Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3. Virology

The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8

Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination

Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission

Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China

Computational Inference of Selection Underlying the Evolution of the Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2

Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses. mBio

Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution

Positive Selection of ORF1ab, ORF3a, and ORF8 Genes Drives the Early Evolutionary Trends of SARS-CoV-2 During the 2020 COVID-19 Pandemic

Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2. mBio

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study

Different mutations in SARS-CoV-2 associate with severe and mild outcome

Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirus

Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice

Expression, post-translational modification and biochemical characterization of proteins encoded by subgenomic mRNA8 of the severe acute respiratory syndrome coronavirus

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence. Pathogens

Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein. mBio

The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNgamma-Induced Antiviral Gene Expression in Human Lung Epithelial Cells. Front Immunol

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection

The ORF8 protein of SARS-CoV-2 mediates immune evasion through downregulating MHC-Iota

ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. iScience

Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages

Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine

Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells

A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research

In-gel digestion for mass spectrometric characterization of proteins and proteomes

GISAID: Global initiative on sharing all influenza data -from vision to reality

An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infection

Measuring ER stress and the unfolded protein response using mammalian tissue culture system

Tunicamycin-induced unfolded protein response in the developing mouse brain

Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein

SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes

The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion through Potently Downregulating MHC-I. bioRxiv

The protein X4 of severe acute respiratory syndrome-associated coronavirus is expressed on both virus-infected cells and lung tissue of severe acute respiratory syndrome patients and inhibits growth of Balb/c 3T3 cell line

Screening for Novel Endogenous Inflammatory Stimuli Using the Secreted Embryonic Alkaline Phosphatase NF-kappaB Reporter Assay

The host immune response in respiratory virus infection: balancing virus clearance and immunopathology

Author Correction: Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Interleukin-6 in Covid-19: A systematic review and metaanalysis

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles

Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant